FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Curable patents



      
           
This page is updated frequently with new Curable-related patents. Subscribe to the Curable RSS feed to automatically get the update: related Curable RSS feeds.

Subscribe to updates on this page: Curable RSS RSS

Date/App# patent app List of recent Curable-related patents
03/20/14
20140082757
 Transformed caenorhabditis elegans and method for screening for substances regulating glucose metabolism using same patent thumbnailTransformed caenorhabditis elegans and method for screening for substances regulating glucose metabolism using same
The present invention relates to a method for preparing a transformed caenorhabditis elegans (c. Elegans) which reacts to glucose by exhibiting fluorescence, and to a method for screening for a candidate substance and for a novel gene capable of regulating glucose metabolism and metabolic diseases using the transformed caenorhabditis elegans.
02/27/14
20140057350
 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation patent thumbnailCompositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hes) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media.
02/27/14
20140057250
 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation patent thumbnailCompositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hes) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media.
02/20/14
20140051164
 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation patent thumbnailCompositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hes) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media.
02/20/14
20140051110
 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation patent thumbnailCompositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hes) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media.
02/20/14
20140050706
 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation patent thumbnailCompositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hes) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media.
01/30/14
20140027952
 Methods for producing coaxial structures using a microfluidic jet patent thumbnailMethods for producing coaxial structures using a microfluidic jet
The object of the invention is the provision of methods for controlled production of continuous multi-component filaments or discreet structures using a multi-component liquid jet issuing from an orifice. A multi-component jet consists of two or more liquids.
01/23/14
20140024737
 Mill base composition and uv curable ink composition comprising same patent thumbnailMill base composition and uv curable ink composition comprising same
A mill base composition includes a compound comprising a divinyl ester of a dicarboxylic acid, a dispersing agent, and a pigment. The divinyl ester of the carboxylic acid includes from 2 to about 8 carbon atoms.
12/19/13
20130335494
 Digital inkjet printing machine with transparent ink patent thumbnailDigital inkjet printing machine with transparent ink
A digital inkjet printing machine with transparent ink comprising an inkjet module, at least one uv light projection device and a working platform with heating function is disclosed, wherein the working platform is used for heating a work piece during or after the jetting of ink on the work piece on the working platform for hardening the ink droplets thereon, and the inkjet module has a plurality of colored ink cartridges and at least one transparent ink cartridge filled with transparent uv curable ink; the at least one uv light projection device is disposed on a side of the inkjet module for irradiating uv light downward on a surface of the work piece on the working platform in order to solidify the transparent uv curable ink droplets jetted thereon, and to form a three-dimensional transparent color layer on the surface of the printed work piece.. .
10/10/13
20130267718
 Novel amide gellant compositions containing isosorbide patent thumbnailNovel amide gellant compositions containing isosorbide
Disclosed herein are ester-terminated polyamide gellant compounds end-caped with isosorbide and uv curable ink compositions containing them.. .
10/10/13
20130267624
Novel ink compositions containing isosorbide-capped amide gellant
Disclosed herein are ester-terminated polyimide gellant compounds end-caped with isosorbide and uv curable ink compositions containing them.. .
09/26/13
20130250001
Reduced gloss banding through low ink volume deposition per print pass
Improved output quality of a printer used in uv curable ink jet printing is achieved by minimizing or eliminating a print artifact referred to as gloss banding or tire tracking. A same or a similar number of nozzles as used in conventional printers is used to achieve a desired throughput, but the nozzles are arranged so that any given square inch of substrate to which ink is being applied receives a lower amount of ink.
08/01/13
20130194365
Separation of electromagnetic radiation of electromagnetic spectrum to cure ink
An image forming apparatus includes an ink applicator unit to selectively apply ultraviolet (uv) curable ink on a media, a media support unit to support the media to receive the uv curable ink, and a uv radiation curing device to cure the uv curable ink on the media. The uv radiation curing device includes a uv radiation source module to emit an electromagnetic spectrum and a dispersion member.
05/16/13
20130122588
Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hes) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media.
05/16/13
20130122486
Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hes) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media.
05/09/13
20130113868
Inkjet printing apparatus and a method for printing ultraviolet (uv) curable ink
An inkjet printing apparatus (10, 10′, 10″, 100, 100′) for printing ultraviolet (uv) curable ink (12) includes a printhead assembly (26) for printing the uv curable ink (12) on a substrate (14); a uv radiation source (20) for pinning the uv curable ink (12) printed on the surface of the substrate (14); a liquid coating unit (22) for dispensing a liquid coating (16) on the printed and pinned uv curable ink (12, 12′); and an ink curing unit (28) for fully curing the printed, pinned, and coated uv curable ink (12, 12′). The liquid coating (16) prevents contact between atmospheric oxygen and the printed and pinned uv curable ink (12, 12′)..
03/28/13
20130078221
Multipotent adult stem cell derived from canine umbilical cord blood, placenta and canine fetus heart, method for preparing the same and cellular therapeutics containing the same
The present invention relates to multipotent adult stem cells derived from canine umbilical cord blood, placental blood and blood sample from canine fetal heart, and a method for preparing the same as well as a cellular therapeutic agent containing the same, more specifically, to a multipotent adult stem cell isolated by culturing an eukaryotic cell derived from canine umbilical cord blood, placental blood and blood sample from canine fetal heart in a fbs-containing medium and a method for preparing the same. Adult stem cells according to the present invention have characteristics highly similar to human mesenchymal stem cells as well as remarkable cell growth at the initial step compared to human ucb-derived mesenchymal stem cells so that the cells are useful to treat canine incurable diseases and difficult-to-cure diseases.
02/28/13
20130050339
Reduced gloss banding through low ink volume deposition per print pass
Improved output quality of a printer used in uv curable ink jet printing is achieved by minimizing or eliminating a print artifact referred to as gloss banding or tire tracking. A same or a similar number of nozzles as used in conventional printers is used to achieve a desired throughput, but the nozzles are arranged so that any given square inch of substrate to which ink is being applied receives a lower amount of ink.
12/31/69
20120276625

. .
12/31/69
20120100606

. .
12/31/69
20120046645

. .
12/31/69
20120045829

. .
12/31/69
20120045466

. .


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patents related to Curable for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Curable with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.1352

1078

2 - 1 - 24